1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M


1 Year 1Y

5 Years 5Y

About Inari Medical Inc

Inari Medical, Inc. is a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases. Inari has developed two minimally-invasive, novel catheter-based mechanical thrombectomy devices that are designed to remove large clots from large vessels and eliminate the need for thrombolytic drugs. The company purpose-built its products for the specific characteristics of the venous system and the treatment of the two distinct manifestations of venous thromboembolism, or VTE: deep vein thrombosis and pulmonary embolism. The ClotTriever system is 510(k)-cleared by the FDA and CE Mark approved for the treatment of deep vein thrombosis. The FlowTriever system is 510(k)-cleared by the FDA and CE Mark approved for the treatment of pulmonary embolism and clot in transit in the right atrium.


Inari Medical Stock Gained 21% on Thursday - Here''s Why It Soared
Aug 03, 2023 20:09pm

Inari Medical Inc (NASDAQ: NARI ) shares gained on Thursday after the company reported Q2 revenues of $119.0 million, up 28.3% Y/Y, beating the consensus of $116.28 million . The increase over the prior year quarter was driven primarily by global commercial expansion, increased adoption of our procedures, and introduction of new products. The company reported Q2 EPS of $0.04, a turnaround from an EPS … Full story available on

Why Shares of Inari Medical Are Up Thursday
Aug 03, 2023 18:26pm

The company announced second-quarter earnings.

Source:The Motley Fool
Inari Medical, Inc. (NARI) Q2 2023 Earnings Call Transcript
Aug 03, 2023 02:10am

Inari Medical, Inc. (NASDAQ:NASDAQ:NARI) Q2 2023 Earnings Call Transcript August 2, 2023 4:30 PM ETCompany ParticipantsJohn Hsu - Vice President of Investor RelationsDrew Hykes - President…

Source:Seeking Alpha
Inari Medical GAAP EPS of $0.04 beats by $0.16, revenue of $119M beats by $2.28M
Aug 02, 2023 20:25pm

Inari Medical press release (NARI): Q2 GAAP EPS of $0.04 beats by $0.16.Revenue of $119M (+28.4% Y/Y) beats by $2.28M.For the full year 2023, we are raising our revenue guidance to…

Source:Seeking Alpha
Inari Medical Q2 2023 Earnings Preview
Aug 01, 2023 21:35pm

Inari Medical (NARI) is scheduled to announce Q2 earnings results on Wednesday, August 2nd, after market close.The consensus EPS Estimate is -$0.12 and the consensus Revenue Estimate…

Source:Seeking Alpha
Inari Medical: Approaching Interesting Levels
Jul 31, 2023 10:06am

Inari Medical shares have been lagging after seeing strong momentum post its IPO in 2020. Click here to see why NARI stock is a Hold.

Source:Seeking Alpha